AMGEN 23/30AMGEN 23/30AMGEN 23/30

AMGEN 23/30

No trades
See on Supercharts

US31162DQ0 analysis



Key facts


Issue date
Mar 2, 2023
Maturity date
Mar 2, 2030
Outstanding amount
‪2.75 B‬USD
Face value
1,000.00USD
Minimum denomination
2,000.00USD
Coupon
5.25% (Fixed)
Yield to maturity
4.94%
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.